Fludarabine
Lung Disease
PfizerSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Lung Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Interferon Gamma-1B InterMune | Phase 3 | B |
Azathioprine InterMune | Phase 3 | B |
Imatinib Daniels, Craig E., M.D. | Phase 2/3 | B |
pf-08634404 Pfizer | Phase 2 | CCC |
Inomax Mallinckrodt | Phase 2 | CCC |
View all 12 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →